Firebrick Pharma
(ASX) FRE
Firebrick Pharma Financials at a Glance
Market Cap
$14.34M
Revenue (TTM)
$1.51M
Net Income (TTM)
$4.18M
EPS (TTM)
$-0.01
P/E Ratio
-5.38
Dividend
$0.00
Beta (Volatility)
0.13 (Low)
Dividend
$0.00
Beta (Volatility)
0.13 (Low)
Price
$0.06
Volume
280,757
Open
$0.06
Price
$0.06
Volume
280,757
Open
$0.06
Previous Close
$0.06
Daily Range
$0.06 - $0.06
52-Week Range
$0.05 - $0.09
Dividend
$0.00
Beta (Volatility)
0.13 (Low)
Price
$0.06
Volume
280,757
Open
$0.06
Previous Close
$0.06
Daily Range
$0.06 - $0.06
52-Week Range
$0.05 - $0.09
FRE News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Firebrick Pharma
Industry
Pharmaceuticals
Sector
Health CareCEO
Peter Laurence Molloy, PhD, MBA
Website
www.firebrickpharma.comHeadquarters
Melbourne, VIC 3000, AU
FRE Financials
Key Financial Metrics (TTM)
Gross Margin
-68%
Operating Margin
-6%
Net Income Margin
-6%
Return on Equity
-143%
Return on Capital
-1%
Return on Assets
-1%
Earnings Yield
-18.59%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$14.34M
Shares Outstanding
251.57M
Volume
280.76K
Short Interest
0.00%
Avg. Volume
70.34K
Financials (TTM)
Gross Profit
$104.82K
Operating Income
$2.87M
EBITDA
$2.86M
Operating Cash Flow
$1.78M
Capital Expenditure
$82.98K
Free Cash Flow
$1.86M
Cash & ST Invst.
$983.35K
Total Debt
$0.00
Firebrick Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$63.27K
-93.0%
Gross Profit
$447.34K
-149.5%
Gross Margin
-7.07%
N/A
Market Cap
$14.34M
N/A
Market Cap/Employee
$2.39M
N/A
Employees
6
N/A
Net Income
$1.26M
-40.6%
EBITDA
$1.29M
-44.6%
Quarterly Fundamentals
Net Cash
$1.44M
+10.0%
Accounts Receivable
$39.09K
+630.2%
Inventory
$513.21K
+81.2%
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-1.07%
N/A
Return on Invested Capital
-1.21%
N/A
Free Cash Flow
$1.05M
-3.9%
Operating Cash Flow
$1.05M
-3.9%